Ned Pagliarulo, Jonathan Gardner and Ben Fidler's articles Biotechnology ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH mid-stage findings for important new medicines. Written by Ned Pagliarulo, Jonathan Gardner and Ben Fidler December 10, 2024December 10, 2024 Saving Bookmark this article Bookmarked
Biotechnology ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH mid-stage findings for important new medicines. Written by Ned Pagliarulo, Jonathan Gardner and Ben Fidler December 10, 2024December 10, 2024 Saving Bookmark this article Bookmarked
